Health
COVID-19: Cambridge vaccine gets £1.9 million to begin clinical trials – BBC Focus Magazine
Scientists at Cambridge say they aim to make a vaccine that will not only protect from SARS-CoV-2, but also other related coronaviruses.
A coronavirus vaccine candidate developed by the University of Cambridge could begin clinical trials in the UK in the autumn.
A £1.9 million funding boost from Innovate UK, the governments innovation agency, has provided support for a collaboration between Cambridge spin-out company DIOSynVax, the University of Cambridge and the University Hospital Southampton NHS Foundation Trust.
The funding of £1.9 million will allow the team to take the vaccine candidate to clinical trial at the University…
-
Noosa News16 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
General14 hours agoCrowe toasts talkback titan for platforming ‘voiceless’
-
Noosa News16 hours agoBoy charged over E-Bike crash
-
General14 hours agoSingapore’s world-first sustainable flights tax will see some Australians pay more to travel